Fly Labs
Ask FlyBot

How are people doing AI evals these days?

With the buzz that's happening with all the new AI models that get released (what feels like every other week), how are companies running internal AI evals to determine which model is best for their use case?

Hacker NewsToolAISource
0Sign in to voteCopy link

FL score

75

out of 100

Verdict

BUILD

high confidence

Competition

19

competitors found, growing market, big tech present, funded players

Trend

2 community mentions

An AI evaluation tool for companies, focusing on specific underserved niches within a highly competitive but growing market.

The pain

Companies are struggling with internal AI evaluations, leading to production failures, high costs, and a lack of scalable, reliable methods to determine the best models for their use cases. Human eyeballing is insufficient, and existing tools often fall short on specific needs like automated root cause analysis, affordable HIPAA compliance, or resistance to 'goodharting'.

The gap

Despite a crowded market with funded players and open-source tools, specific pain points remain unaddressed. These include the lack of affordable HIPAA-compliant options, automated root cause analysis for agents, and easy custom internal evaluation frameworks resistant to gaming, especially for non-ML experts or specific organizational contexts.

Build angle

Focus on 'Easy Custom Internal Evals for Non-ML Experts in SMBs' or 'Automated Root Cause Analysis for Tool-Using AI Agents' or 'Affordable HIPAA-Compliant Evals for Specific Industry Verticals'. The key is to pick *one* extremely narrow niche with clear evidence of an unserved audience.

Strengths

  • Real, severe, and urgent problem for companies leveraging AI.
  • Clear signals of willingness to pay, with existing paid solutions validating the market.
  • High market growth and excellent timing due to rapid AI model proliferation.
  • Building expertise in AI evals has significant compound value for future AI projects.
  • Value proposition is measurable (cost savings, reliability, production performance).

Risks

  • Extremely crowded market with well-funded incumbents and strong open-source tools.
  • Lack of a clearly defined, evidence-backed unserved niche for a solo builder.
  • High complexity in building a robust, production-grade AI evaluation platform.
  • Distribution and customer acquisition challenges in a noisy market.
  • Risk of 'goodharting' or bias in any new evaluation metrics without careful design.

Next steps

  1. Conduct in-depth user interviews with AI engineers, product managers, and decision-makers at SMBs to identify their precise pain points related to AI evals not currently solved by existing tools.
  2. Validate demand for specific narrow angles (e.g., 'affordable HIPAA-compliant evals for healthcare AI startups' or 'automated root cause analysis for tool-using agents') by pitching a simplified solution and asking for pre-orders or letters of intent.
  3. Explore leveraging existing open-source frameworks (DeepEval, RAGAS, Opik) as a base to accelerate MVP development for the chosen niche.
  4. Focus intensely on building a single, critical feature that provides immediate, undeniable value to the validated niche, rather than a broad platform.

Questions about this idea?

FlyBot reads the scoring and gives you a second opinion on “How are people doing AI evals these days?”.

Open FlyBot